The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
718 - If a efile was previously exempted and no changes were made, does the file need to go through PAAB assessment again (re-exemption)?
-
A piece that has been deemed exempt does not require “re-exemption” as the piece does not require review. If something has changed in the marketplace to prompt the re-evaluation of whether something is exempt, than it may require a new look. Assuming that nothing has changed that may challenge the exempt ruling, no approval number is given and therefore no expiry date applies.
